The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States

BACKGROUND: The US National HIV/AIDS Strategy (NHAS) aims for 72% (90% diagnosed times 80% of those virally suppressed) viral suppression among persons with human immunodeficiency virus (HIV) by 2020. We examined the clinical and economic impact of reaching this target, in the general US population...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Autores principales: Borre, Ethan D, Hyle, Emily P, Paltiel, A David, Neilan, Anne M, Sax, Paul E, Freedberg, Kenneth A, Weinstein, Milton C, Walensky, Rochelle P
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2017
Materias:
Major Articles and Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853503/
https://ncbi.nlm.nih.gov/pubmed/29029344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix349
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares